Environmental Monitoring Commitments: Post-Approval Expectations for High-Risk APIs in 2023 Environmental Monitoring Commitments: Post-Approval Expectations for High-Risk APIs in 2023 The pharmaceutical industry is increasingly recognizing the importance of Environmental Monitoring Commitments, particularly as regulatory frameworks evolve to address environmental risks associated with Active Pharmaceutical Ingredients (APIs). This guide outlines a step-by-step approach to understanding and implementing post-approval expectations for high-risk APIs, focusing primarily on compliance in the United States. Step 1: Understanding Regulatory Requirements for High-Risk APIs In order to effectively manage Environmental Monitoring Commitments, it’s essential to first understand the relevant regulatory landscape. The FDA and EMA, along…